MXPA01003761A - Agente para tratar oftalmopatia. - Google Patents
Agente para tratar oftalmopatia.Info
- Publication number
- MXPA01003761A MXPA01003761A MXPA01003761A MXPA01003761A MXPA01003761A MX PA01003761 A MXPA01003761 A MX PA01003761A MX PA01003761 A MXPA01003761 A MX PA01003761A MX PA01003761 A MXPA01003761 A MX PA01003761A MX PA01003761 A MXPA01003761 A MX PA01003761A
- Authority
- MX
- Mexico
- Prior art keywords
- remedies
- ocular diseases
- ocular
- diseases
- Prior art date
Links
- 208000022873 Ocular disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29019498 | 1998-10-13 | ||
| PCT/JP1999/005605 WO2000021531A1 (en) | 1998-10-13 | 1999-10-12 | Remedies for ocular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01003761A true MXPA01003761A (es) | 2003-07-21 |
Family
ID=17752981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01003761A MXPA01003761A (es) | 1998-10-13 | 1999-10-12 | Agente para tratar oftalmopatia. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6451787B1 (es) |
| EP (1) | EP1121932A4 (es) |
| KR (1) | KR20010083884A (es) |
| CN (1) | CN1323208A (es) |
| AU (1) | AU6007599A (es) |
| CA (1) | CA2347519A1 (es) |
| MX (1) | MXPA01003761A (es) |
| NZ (1) | NZ511084A (es) |
| WO (1) | WO2000021531A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2454544A1 (en) * | 2001-07-02 | 2003-01-16 | Santen Pharmaceutical Co., Ltd. | Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient |
| WO2005082920A1 (en) | 2004-02-27 | 2005-09-09 | H. Lundbeck A/S | Crystalline forms of a pharmaceutical compound |
| MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| US20060275797A1 (en) * | 2005-03-21 | 2006-12-07 | Alcon Manufacturing, Ltd. | Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders |
| PL1864666T3 (pl) * | 2005-03-31 | 2013-02-28 | Agc Inc | Czynnik ochronny dla komórki neuronalnej siatkówki zawierający jako składnik aktywny pochodną prostaglandyny F2 alfa |
| WO2007002670A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Method of lowering intraocular pressure |
| JP2009521493A (ja) * | 2005-12-23 | 2009-06-04 | アルコン，インコーポレイテッド | 眼への受容体チロシンキナーゼ阻害（ＲＴＫｉ）化合物の送達のための医薬製剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5461146A (en) | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
| US5798380A (en) | 1996-02-21 | 1998-08-25 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
| UA65542C2 (uk) | 1996-06-25 | 2004-04-15 | Сефалон, Інк. | Спосіб пригнічення надлишкового продукування фактора некрозу пухлин альфа , спосіб полегшення шкідливих ефектів надлишкового продукування фактора некрозу пухлин альфа та спосіб лікування запального стану або захворювання, пов'язаного з фактором некрозу пухлин. |
| US6200968B1 (en) * | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
-
1999
- 1999-10-12 CN CN99812057A patent/CN1323208A/zh active Pending
- 1999-10-12 WO PCT/JP1999/005605 patent/WO2000021531A1/ja not_active Ceased
- 1999-10-12 NZ NZ511084A patent/NZ511084A/en unknown
- 1999-10-12 AU AU60075/99A patent/AU6007599A/en not_active Abandoned
- 1999-10-12 MX MXPA01003761A patent/MXPA01003761A/es unknown
- 1999-10-12 EP EP99970320A patent/EP1121932A4/en not_active Withdrawn
- 1999-10-12 KR KR1020017004194A patent/KR20010083884A/ko not_active Withdrawn
- 1999-10-12 US US09/807,293 patent/US6451787B1/en not_active Expired - Fee Related
- 1999-10-12 CA CA002347519A patent/CA2347519A1/en not_active Abandoned
-
2002
- 2002-08-26 US US10/228,645 patent/US20030013701A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1121932A4 (en) | 2001-12-19 |
| NZ511084A (en) | 2004-01-30 |
| US20030013701A1 (en) | 2003-01-16 |
| AU6007599A (en) | 2000-05-01 |
| KR20010083884A (ko) | 2001-09-03 |
| US6451787B1 (en) | 2002-09-17 |
| EP1121932A1 (en) | 2001-08-08 |
| CN1323208A (zh) | 2001-11-21 |
| CA2347519A1 (en) | 2000-04-20 |
| WO2000021531A1 (en) | 2000-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5732699A (en) | Corneal onlay | |
| HUP0200994A3 (en) | Remedies for immunological diseases | |
| ZA991307B (en) | Antibodies against human CD40. | |
| ZA99283B (en) | Inhaler for medication. | |
| AU3837300A (en) | Remedies | |
| AU5651799A (en) | Remedies for photochemotherapy | |
| ZA995444B (en) | A method for the treatment of staphylococcal disease. | |
| ZA99733B (en) | Ophthalmic composition. | |
| ZA200108489B (en) | Tampon. | |
| MXPA01003761A (es) | Agente para tratar oftalmopatia. | |
| EP1213021A4 (en) | MEDICINE AGAINST DIABETES | |
| AU3328600A (en) | Ocular tension-lowering agents | |
| ZA200110539B (en) | Oxazinocarbazoles for the treatment of CNS diseases. | |
| EP1010433A4 (en) | MEDICINE FOR DISEASES CAUSED BY INSULIN RESISTANCE | |
| ZA200110046B (en) | Therapeutic agents. | |
| ZA991783B (en) | Therapeutic treatment for autoimmune diseases. | |
| EP1252895A4 (en) | REMEDIES FOR OPHTHALMIC DISORDERS | |
| GB9920336D0 (en) | Retinoscope | |
| AU5713400A (en) | The health mask | |
| AU2001271026A1 (en) | Remedies for bone diseases | |
| AU2461200A (en) | Remedies | |
| AU5294999A (en) | Defensins against ocular infection | |
| ZA991786B (en) | Therapeutic treatment for asthma. | |
| EP1097717A4 (en) | MEDICINE FOR APOPTOSIS ASSOCIATED DISEASES | |
| EP0774260A4 (en) | REMEDY FOR CORNEAL AFFECTIONS |